Terms: = Leukemia AND LYL1, P12980, 4066, ENSG00000104903 AND Prognosis
9 results:
1. BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene lyl1 in Acute Myeloid leukemia.
Sang X; Zhang Y; Fang F; Gao L; Tao Y; Li X; Zhang Z; Wang J; Tian Y; Li Z; Yao D; Wu Y; Chu X; Zhang K; Ma L; Lu L; Chen Y; Yu J; Zhuo R; Wu S; Zhang Z; Pan J; Hu S
J Immunol Res; 2022; 2022():7912484. PubMed ID: 35958877
[TBL] [Abstract] [Full Text] [Related]
2. Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia.
Chen B; Jiang L; Zhong ML; Li JF; Li BS; Peng LJ; Dai YT; Cui BW; Yan TQ; Zhang WN; Weng XQ; Xie YY; Lu J; Ren RB; Chen SN; Hu JD; Wu DP; Chen Z; Tang JY; Huang JY; Mi JQ; Chen SJ
Proc Natl Acad Sci U S A; 2018 Jan; 115(2):373-378. PubMed ID: 29279377
[TBL] [Abstract] [Full Text] [Related]
3. Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation.
Bruserud Ø; Reikvam H; Fredly H; Skavland J; Hagen KM; van Hoang TT; Brenner AK; Kadi A; Astori A; Gjertsen BT; Pendino F
Oncotarget; 2015 Feb; 6(5):2794-811. PubMed ID: 25605239
[TBL] [Abstract] [Full Text] [Related]
4. Requirement for lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
[TBL] [Abstract] [Full Text] [Related]
5. Precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma and acute biphenotypic leukemias.
Han X; Bueso-Ramos CE
Am J Clin Pathol; 2007 Apr; 127(4):528-44. PubMed ID: 17369128
[TBL] [Abstract] [Full Text] [Related]
6. Gene expression profiling in T-cell acute lymphoblastic leukemia.
Ferrando AA; Look AT
Semin Hematol; 2003 Oct; 40(4):274-80. PubMed ID: 14582078
[TBL] [Abstract] [Full Text] [Related]
7. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis.
Ballerini P; Blaise A; Busson-Le Coniat M; Su XY; Zucman-Rossi J; Adam M; van den Akker J; Perot C; Pellegrino B; Landman-Parker J; Douay L; Berger R; Bernard OA
Blood; 2002 Aug; 100(3):991-7. PubMed ID: 12130513
[TBL] [Abstract] [Full Text] [Related]
8. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
Ferrando AA; Neuberg DS; Staunton J; Loh ML; Huard C; Raimondi SC; Behm FG; Pui CH; Downing JR; Gilliland DG; Lander ES; Golub TR; Look AT
Cancer Cell; 2002 Feb; 1(1):75-87. PubMed ID: 12086890
[TBL] [Abstract] [Full Text] [Related]
9. Heterogeneity of t(1;19)(q23;p13) acute leukaemias. French Haematological Cytology Group.
Troussard X; Rimokh R; Valensi F; Leboeuf D; Fenneteau O; Guitard AM; Manel AM; Schillinger F; Leglise C; Brizard A
Br J Haematol; 1995 Mar; 89(3):516-26. PubMed ID: 7734349
[TBL] [Abstract] [Full Text] [Related]
